Literature DB >> 30120778

Defining Regional Differences in Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Tool to Improve Drug Safety?

Elizabeth J Phillips1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30120778      PMCID： PMC6312457          DOI： 10.1002/cpt.1175

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  10 in total

1.  Medical genetics: a marker for Stevens-Johnson syndrome.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Hong-Shang Hong; Mo-Song Hsih; Li-Cheng Yang; Hsin-Chun Ho; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

2.  Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.

Authors:  Patricia T Illing; Julian P Vivian; Nadine L Dudek; Lyudmila Kostenko; Zhenjun Chen; Mandvi Bharadwaj; John J Miles; Lars Kjer-Nielsen; Stephanie Gras; Nicholas A Williamson; Scott R Burrows; Anthony W Purcell; Jamie Rossjohn; James McCluskey
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

3.  Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.

Authors:  David A Ostrov; Barry J Grant; Yuri A Pompeu; John Sidney; Mikkel Harndahl; Scott Southwood; Carla Oseroff; Shun Lu; Jean Jakoncic; Cesar Augusto F de Oliveira; Lun Yang; Hu Mei; Leming Shi; Jeffrey Shabanowitz; A Michelle English; Amanda Wriston; Andrew Lucas; Elizabeth Phillips; Simon Mallal; Howard M Grey; Alessandro Sette; Donald F Hunt; Soren Buus; Bjoern Peters
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

4.  Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study.

Authors:  Sarah F Keller; Na Lu; Kimberly G Blumenthal; Sharan K Rai; Chio Yokose; Jee Woong J Choi; Seoyoung C Kim; Yuqing Zhang; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2018-04-13       Impact factor: 19.103

5.  Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.

Authors:  S Mallal; D Nolan; C Witt; G Masel; A M Martin; C Moore; D Sayer; A Castley; C Mamotte; D Maxwell; I James; F T Christiansen
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

6.  Risk factor analysis of hypersensitivity reactions to abacavir.

Authors:  William Symonds; Amy Cutrell; Mark Edwards; Helen Steel; Bill Spreen; Gwendolyn Powell; Sue McGuirk; Seth Hetherington
Journal:  Clin Ther       Date:  2002-04       Impact factor: 3.393

7.  Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.

Authors:  Seth Hetherington; Arlene R Hughes; Michael Mosteller; Denise Shortino; Katherine L Baker; William Spreen; Eric Lai; Kirstie Davies; Abigail Handley; David J Dow; Mary E Fling; Michael Stocum; Clive Bowman; Linda M Thurmond; Allen D Roses
Journal:  Lancet       Date:  2002-03-30       Impact factor: 79.321

8.  Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.

Authors:  Wen-Hung Chung; Wan-Chun Chang; Yun-Shien Lee; Ying-Ying Wu; Chih-Hsun Yang; Hsin-Chun Ho; Ming-Jing Chen; Jing-Yi Lin; Rosaline Chung-Yee Hui; Ji-Chen Ho; Wei-Ming Wu; Ting-Jui Chen; Tony Wu; Yih-Ru Wu; Mo-Song Hsih; Po-Hsun Tu; Chen-Nen Chang; Chien-Ning Hsu; Tsu-Lan Wu; Siew-Eng Choon; Chao-Kai Hsu; Der-Yuan Chen; Chin-San Liu; Ching-Yuang Lin; Nahoko Kaniwa; Yoshiro Saito; Yukitoshi Takahashi; Ryosuke Nakamura; Hiroaki Azukizawa; Yongyong Shi; Tzu-Hao Wang; Shiow-Shuh Chuang; Shih-Feng Tsai; Chee-Jen Chang; Yu-Sun Chang; Shuen-Iu Hung
Journal:  JAMA       Date:  2014-08-06       Impact factor: 56.272

9.  HLA-B*5701 screening for hypersensitivity to abacavir.

Authors:  Simon Mallal; Elizabeth Phillips; Giampiero Carosi; Jean-Michel Molina; Cassy Workman; Janez Tomazic; Eva Jägel-Guedes; Sorin Rugina; Oleg Kozyrev; Juan Flores Cid; Phillip Hay; David Nolan; Sara Hughes; Arlene Hughes; Susanna Ryan; Nicholas Fitch; Daren Thorborn; Alastair Benbow
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

Review 10.  Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Authors:  Jonathan Grant Peter; Rannakoe Lehloenya; Sipho Dlamini; Kimberly Risma; Katie D White; Katherine C Konvinse; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun
  10 in total
  1 in total

Review 1.  Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances.

Authors:  Teresa Bellón
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.228
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.